News of Note—HPV vaccination, Imutex's universal flu shot and more

non
In this week's news of note, healthcare providers are found to recommend HPV vaccine more often to girls than boys. (Pixabay)

Here is some other vaccine news of note for the week:

> A recent study found that healthcare providers are not recommending HPV vaccination to boys as often as to girls. ABC News article

> British firm Imutex’s universal flu vaccine candidate Flu-v turned in positive clinical results and could be available on England's NHS in two years. Daily Mail article

> Altimmune announced positive data from a phase 2a study of its monovalent NasoVAX intranasal flu vaccine. Results showed 100% seroprotection in the mid- and high-dose groups. Release

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.